Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Getting to the heart of the matter: cardiac involvement in transthyretin-related amyloidosis.

Zeldenrust SR, Cooper LT.

Eur Heart J. 2013 Feb;34(7):483-5. doi: 10.1093/eurheartj/ehs238. Epub 2012 Aug 26. No abstract available.

2.

Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.

Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A, Arpesella G, Pinna AD, Merlini G, Perlini S.

Eur Heart J. 2013 Feb;34(7):520-8. doi: 10.1093/eurheartj/ehs123. Epub 2012 Jun 28.

3.

Amyloid heart disease mimicking hypertrophic cardiomyopathy.

Mörner S, Hellman U, Suhr OB, Kazzam E, Waldenström A.

J Intern Med. 2005 Sep;258(3):225-30.

4.

Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.

Yin J, Xia X, Shi Y, Lu Y, Zhao C, Huang Z, Tian N.

Amyloid. 2014 Jun;21(2):140-2. doi: 10.3109/13506129.2014.892871. Epub 2014 Mar 6. Review. No abstract available.

PMID:
24601824
5.

Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.

Damy T, Plante-Bordeneuve V, Dogan A.

Arch Cardiovasc Dis. 2014 Dec;107(12):706-8. doi: 10.1016/j.acvd.2012.09.008. Epub 2013 Sep 23. No abstract available.

6.

[Familial transthyretin amyloidosis with Gly47Arg mutation and cardiac involvement: a case report].

Fan J, Wu W, Chen W, Chen L, Guan H, Lu C, Fang Q, Yan X.

Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Sep;42(9):784-5. Chinese. No abstract available.

PMID:
25511101
7.

Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.

Niemczyk R, Brydak-Godowska J, Kecik D, Wagner T, Lewandowski P, Kecik M, Zygier D, Ołdakowska-Jedynak U.

Transplant Proc. 2009 Oct;41(8):3085-7. doi: 10.1016/j.transproceed.2009.07.089.

PMID:
19857683
8.

Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis.

Briani C, Cavallaro T, Ferrari S, Taioli F, Calamelli S, Verga L, Adami F, Fabrizi GM.

J Neurol. 2012 Oct;259(10):2226-8. doi: 10.1007/s00415-012-6529-z. Epub 2012 May 12. No abstract available.

PMID:
22580845
9.

Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.

Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S.

Amyloid. 2003 Dec;10(4):229-39.

PMID:
14986482
10.

Delayed diagnosis of transthyretin amyloidosis with a novel mutation (c.210T>A) in the transthyretin gene.

Dekmezian MS, Tschen JA, Cho-Vega JH.

J Am Acad Dermatol. 2013 Feb;68(2):e49-51. doi: 10.1016/j.jaad.2012.07.026. No abstract available.

PMID:
23317988
11.

THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.

Coelho T, Maurer MS, Suhr OB.

Curr Med Res Opin. 2013 Jan;29(1):63-76. doi: 10.1185/03007995.2012.754348. Epub 2012 Dec 13.

PMID:
23193944
12.

Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.

Tsuchiya-Suzuki A, Yazaki M, Kametani F, Sekijima Y, Ikeda S.

Hum Pathol. 2011 Feb;42(2):236-43. doi: 10.1016/j.humpath.2010.06.014. Epub 2010 Nov 5.

PMID:
21056899
13.

Clinical variant of familial amyloid polyneuropathy.

Quan D, Cohen JA.

Muscle Nerve. 2002 Sep;26(3):417-20.

PMID:
12210373
14.

Carpal tunnel syndrome as an initial manifestation in a case of transthyretin-related familial amyloid polyneuropathy with a novel A120T mutation.

Koyama S, Kawanami T, Kurokawa K, Tanji H, Iseki C, Arawaka S, Wada M, Kato T.

Clin Neurol Neurosurg. 2012 Jul;114(6):707-9. doi: 10.1016/j.clineuro.2011.11.030. Epub 2011 Dec 30. No abstract available.

PMID:
22209138
15.

Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.

Roe RH, Fisher Y, Eagle RC Jr, Fine HF, Cunningham ET Jr.

Ophthalmology. 2007 Nov;114(11):e33-7.

PMID:
17980738
16.

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.

Sattianayagam PT, Hahn AF, Whelan CJ, Gibbs SD, Pinney JH, Stangou AJ, Rowczenio D, Pflugfelder PW, Fox Z, Lachmann HJ, Wechalekar AD, Hawkins PN, Gillmore JD.

Eur Heart J. 2012 May;33(9):1120-7. doi: 10.1093/eurheartj/ehr383. Epub 2011 Oct 11.

17.

Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.

Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, Shinriki S, Kawahara S, Jono H, Obayashi K, Ogawa H, Ando Y.

Mod Pathol. 2011 Dec;24(12):1533-44. doi: 10.1038/modpathol.2011.117. Epub 2011 Aug 5.

18.

Transthyretin-related familial amyloidotic polyneuropathy.

Ando Y, Nakamura M, Araki S.

Arch Neurol. 2005 Jul;62(7):1057-62. Review.

PMID:
16009758
19.

Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.

Muller KR, Padbury R, Jeffrey GP, Poplawski NK, Thompson P, Tonkin A, Harley HA.

Liver Transpl. 2010 Apr;16(4):470-3. doi: 10.1002/lt.22019.

20.

Cardiac amyloidosis with gastrointestinal involvement: a case report.

Tantau A, Avram I, Cozma A, Sampelean D.

Med Ultrason. 2015 Mar;17(1):123-5. doi: 10.11152/mu.2013.2066.171.atia.

Items per page

Supplemental Content

Write to the Help Desk